Latest Fy26 Outlook News

Southern Cross Electrical Engineering reported a strong half-year EBITDA growth of 30.8% despite a $46.1 million legal settlement impacting net profit. The company raised its full-year EBITDA guidance amid a robust project pipeline and ongoing diversification.

PEXA Group has announced its strategic exit from majority-owned Digital Solutions businesses, triggering a $26 million impairment and a restatement of its FY26 financial guidance. The move signals a sharper focus on core operations amid restructuring costs.

The a2 Milk Company has reported robust half-year results with strong revenue and earnings growth, driven by gains in infant formula and liquid milk segments, alongside a strategic supply chain transformation. The company has upgraded its full-year outlook and announced a substantial special dividend, signalling confidence in its growth trajectory.

Breville Group Limited has reported a record half-year revenue of AUD 1.1 billion, overcoming US tariff challenges through strategic manufacturing shifts and robust product innovation. The company’s steady profitability and geographic expansion signal a confident growth trajectory.

CSL Limited has released its half-year results showing a slight revenue decline amid ongoing transformation efforts, while maintaining its full-year guidance and expanding its share buyback program.

Bravura Solutions has raised its FY26 revenue and cash EBITDA guidance, reflecting robust project engagement and disciplined cost management. The company also plans increased investment in internal technology.

CAR Group has reported strong first-half results for FY26, with double-digit revenue and earnings growth across all key regions, underpinned by strategic AI investments and expanding market presence.

Jcurve Solutions has reported a robust first half of FY26, posting a 32% increase in revenue and a remarkable 478% jump in EBITDA, while upgrading its full-year revenue guidance amid ongoing customer churn challenges.

Centuria Office REIT (ASX, COF) reports a robust HY26 performance marked by significant leasing activity, a notable valuation uplift, and reaffirmed full-year guidance, underscoring a new cycle of recovery in the Australian office market.

Microba Life Sciences reports robust year-on-year growth in microbiome testing volumes and revenue, advancing towards regional break-even in Australia and the UK while progressing its therapeutic pipeline.

Change Financial Limited has reported a record revenue quarter driven by its Vertexon platform growth and new client wins, prompting an upgrade to its FY26 financial guidance.

Change Financial has reported a robust first half of FY26, with revenue and EBITDA surpassing expectations, prompting an upgraded full-year guidance and signalling a key milestone in cash flow positivity.